pharmaceutical companies manufacturing glp-1 receptor agonist medications Market Size & Share Report, 2032 GLP-1 Receptor Agonist Market Size

Several drugs are in advanced clinical trials: In Phase III trials: IBI362 (Innovent/Eli Lilly), CagriSema (Novo Nordisk), Retatrutide (Eli Lilly), and Survodutide (Boehringer Ingelheim)

Naproxen A powerful NSAID (non-steroidal anti-inflammatory) medication that reduces inflammation and offers effective relief from period cramps

For instance, in aged high-fat diet-fed female mice with experimental HFpEF induced by angiotensin II infusion, liraglutide treatment (1 mg/kg once daily for 12 weeks) was shown to alleviate cardiac hypertrophy, atrial enlargement, and diastolic dysfunction, as evidenced by increased global longitudinal strain (Withaar et al

p = 0.06) (Table 2)

Drug Type/Class 16.10.3